Email Contact Phone Company Visit Website

SIX Financial Information U.K. Ltd Office

15, Appold Street
London
GB

SIX Financial Information Switzerland Head Office

Hardturmstrasse 201 Postfach 1521
Zurich
CH

SIX Financial Information USA Inc., Stamford Office

River Bend Center One Omega Drive, Building 3
Stamford
CT
US

SIX Financial Information USA Inc., New York Office

48 Wall Street, 31st Floor
New York
NY
US

SIX Financial Information France Office

91/93 avenue François-Arago
Nanterre cedex
FR

SIX Financial Information Deutschland GmbH Office

Theodor-Heuss-Allee 108
Frankfurt am Main
DE

SIX Financial Information Japan Ltd Office

Hulic Kakigaracho Bldg. 5F 1-28-5, Nihonbashi Kakigaracho, Chuo-ku
Tokyo
JP

SIX Financial Information Luxembourg S.A. Office

15, rue Léon Laval Zone d'activités Am Bann
Leudelange
LU

SIX Financial Information Nederland B.V. Office

Gebouw Rivierstaete, 8th floor Amsteldijk 166
Amsterdam
NL

SIX Financial Information Deutschland GmbH, Austria Office

Zweigniederlassung Wien Wipplingerstrasse 34
Vienna
AT

SIX Financial Information Italia S.r.l. Office

Via del Vecchio Politecnico 3
Milan
IT

SIX Financial Information Belgium S.A./N.V. Office

9, bd de la Plaine/Pleinlaan
Bruxelles
BE

SIX Financial Information Singapore Pte. Ltd. Office

5 Temasek Boulevard #16-01 Suntec Tower Five
Singapore
SG

SIX Financial Information Ireland Office

Arena House Arena Road Sandyford
Dublin
IE

SIX Financial Information UK Ltd., Scotland Office

9/10 St Andrew Square
Edinburgh
GB

SIX Financial Information USA Inc. Office

First Canadian Place 100 King Street, Suite 5700
Toronto
CA

SIX Financial Information Denmark A/S Office

Nikolaj Plads 2, 5
Copenhagen
DK

SIX Financial Information Finland Oy Office

Aleksanterinkatu (WTC)
Helsinki
FI

SIX Financial Information Monaco SAM Office

"Les Acanthes" 6, avenue des Citronniers
Monaco
MC

SIX Financial Information Morocco MENA Office

43, Boulevard d'Anfa
Casablanca
MA

SIX Financial Information Norway AS Office

Holbergsgate 1
Oslo
NO

SIX Financial Information España S.A. Office

Paseo de la Castellana 40bis
Madrid
ES

SIX Financial Information Sweden AB Office

Olof Palmes gata 11 Box 3117
Stockholm
SE

Telephone

+44 (0)20 7550 5411

Contact

Kimberly Neumann
[email protected]
Back to all SIX Financial Information announcements

Index adjustments on the occasion of the ordinary index review

The Management Committee of SIX Swiss Exchange has decided to make changes to SIX Swiss Exchange index baskets on the basis of a recommendation from the Index Commission and in compliance with the SMI®, SLI®, SPI® and SXI® index rules. The indices will be adjusted on 16. September 2011 after closing. The adjustment takes effect on 19 September 2011.

The new index rules for SMI®, SLI® and SPI® are applicable since 1 July 2011.

Changes to the SMI® index basket

Admission to the SMI®
GIVAUDAN N CH0010645932

Exclusion from the SMI®
LONZA N CH0013841017

Changes to the SMIM® index basket

Admissions to the SMIM®
LONZA N CH0013841017
DUFRY N CH0023405456
PARTNERS GROUP N CH0024608827

Exclusions from the SMIM®
GIVAUDAN N CH0010645932
PANALPINA N CH0002168083
BARRY CALLEBAUT N CH0009002962

Changes to the SLI® index basket

Admission to the SLI®
SCHINDLER PS CH0024638196

Exclusion from the SLI®
WEATHERFORD INTERNATIONAL N CH0038838394

SLI® 9% cappings

Based on the SLI® index rules, section 4.1, and according to the half-year rankings, the following securities obtain a weight of 9%:

NESTLE N CH0038863350
NOVARTIS N CH0012005267
ROCHE GS CH0012032048
UBS N CH0024899483

Changes to the SPI® Small, Middle and Large index baskets

Admission to the SPI® Large
WEATHERFORD INTERNATIONAL N CH0038838394

Promotion: Middle to Large
GIVAUDAN N CH0010645932

Demotions: Large to Middle
ACTELION N CH0010532478
LONZA N CH0013841017

Promotions: Small to Middle
DAETWILER I CH0030486770
AUSTRIAMICROSYS AT0000920863

Demotions: Middle to Small
IMPLENIA N CH0023868554
AUTONEUM CH0127480363
ACINO HLDG N CH0021190902

Changes to the SXI Life Sciences® and SXI Bio+Medtech®

Admission to the SXI Life Sciences® and SXI Bio+Medtech®
ORIDION N IL0010837818

Exclusions from the SXI Life Sciences® and SXI Bio+Medtech®
LIFEWATCH N CH0027148649
NEWRON PHARMA N IT0004147952

Changes to the SXI Swiss Real Estate® Funds and SXI Swiss Real Estate® Shares

NO CHANGES TO THE INDEX COMPOSITION